Showing 52,261 - 52,280 results of 52,363 for search '"China"', query time: 0.20s Refine Results
  1. 52261
  2. 52262

    Evaluation on Carbon Sequestration Capacity of 30 Common Landscaping Tree Species in Beijing by Jing QIAN, Sidong SHEN, Shuxin FAN, Li DONG

    Published 2025-01-01
    “…Actively responding to the issue of climate change, China has put forward the carbon peaking and carbon neutrality goals for carbon emission reduction. …”
    Get full text
    Article
  3. 52263
  4. 52264
  5. 52265

    Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy by Yatong Chen, Fei Luo, Tingji Zhang, Jian Li

    Published 2025-01-01
    “…Anti-HER2 RC48-ADC is approved in China for the treatment of patients with advanced urothelial carcinoma with failed chemotherapy who are HER2 positive (IHC 2 + or 3 +). …”
    Get full text
    Article
  6. 52266
  7. 52267

    Association between non-insulin-based insulin resistance indicators and frailty progression: a national cohort study and mendelian randomization analysis by Hui Tian, Yong-meng Li, Cheng-qiang Wang, Guo-qiang Chen, Ying Lian

    Published 2025-01-01
    “…Methods Data from 6722 participants in the China Health and Retirement Longitudinal Study (CHARLS) were analyzed. …”
    Get full text
    Article
  8. 52268
  9. 52269
  10. 52270
  11. 52271
  12. 52272
  13. 52273
  14. 52274
  15. 52275
  16. 52276
  17. 52277
  18. 52278

    Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma by Zhong Zheng, Jian-Biao Wang, Rui Sun, Nan Wang, Xiang-Qin Weng, Tian-Yuan Xu, Di Fu, Yan Feng, Peng-Peng Xu, Shu Cheng, Li Wang, Yan Zhao, Bin Qu, Chuan-Xin Huang, Wei-Li Zhao

    Published 2025-01-01
    “…We conducted the first trial of immunotherapy rituximab plus lenalidomide in newly diagnosed FL in China (NCT03715309). One-hundred and fifteen patients were enrolled and treated with rituximab 375 mg/m2 intravenously on day 0 and lenalidomide 25 mg orally on day 1–10 for 6 cycles of induction treatment, as well as lenalidomide for 6 cycles and rituximab for 8 cycles of maintenance treatment. …”
    Get full text
    Article
  19. 52279

    Serum biomarkers in the metabolic dysfunction-associated steatotic liver fibrosis diagnosis in children by Yu.M. Stepanov, N.Yu. Zavhorodnia, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko

    Published 2024-12-01
    “…Quantitative determination of the serum concentration of vascular endothelial growth factor (VEGF) was performed by enzyme-linked immunosorbent assay (ELISA) using test systems from Wuhan Fine Biotech Co., Ltd (China) according to the manufacturer’s recommendations. …”
    Get full text
    Article
  20. 52280